Internal Medicine, Endocrinology, Diabetes, & Metabolism · Denton, TX
NPI
1710198544
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3300 Colorado Blvd
Denton, TX, 76210
Phone (940) 488-4767
Groups this clinician bills Medicare through
Medicare paid, 2024
$122K
2,581 services
Medicare patients, 2024
438
Average age 74
Drug cost, 2024
$3.4M
5,489 prescriptions
Company payments, 2025
$2,862
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Madhavi Gaddam was code 99214 (office e&m - established), 920 times for 423 patients. In total Madhavi Gaddam billed 2,581 services in 19 codes, and Medicare paid $122K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 920 | 423 | $86.36 | $79K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 622 | 352 | $11.32 | $7,042 |
| 95251 Test - Miscellaneous | Office | 355 | 126 | $24.52 | $8,703 |
| 83036 Blood Count | Office | 94 | 74 | $9.43 | $886 |
| 99204 Office E&M - New | Office | 57 | 57 | $112.33 | $6,403 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 45 | 22 | $40.15 | $1,807 |
| G0506 Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 25 | 25 | $47.60 | $1,190 |
| 99215 Office E&M - Established | Office | 21 | 19 | $131.44 | $2,760 |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 20 | 13 | $101.95 | $2,039 |
| 99205 Office E&M - New | Office | 18 | 18 | $168.04 | $3,025 |
By year: 2022 $106K for 1,899 services; 2023 $102K for 1,737 services; 2024 $122K for 2,581 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 94 | 74 | $9.43 | $886 |
Medicare prescription drug claims, 2024
In 2024, the drug Madhavi Gaddam prescribed most often to Medicare patients was Levothyroxine Sodium, with 441 prescriptions and refills. In total Madhavi Gaddam wrote 5,489 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 441 | 1,277 | 134 | $5,775 |
| Ozempic Semaglutide | 438 | 878 | 120 | $832K |
| Mounjaro Tirzepatide | 317 | 511 | 79 | $536K |
| Jardiance Empagliflozin | 299 | 584 | 82 | $338K |
| Metformin Hcl Generic | 265 | 749 | 85 | $2,916 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 234 | 367 | 55 | $271K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 207 | 512 | 77 | $36K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 186 | 534 | 80 | $21K |
| Metformin Hcl Er Metformin Hcl | 155 | 409 | 47 | $2,737 |
| Atorvastatin Calcium Generic | 151 | 391 | 42 | $1,526 |
| Pioglitazone Hcl Generic | 150 | 422 | 48 | $1,415 |
| Repaglinide Generic | 147 | 394 | 56 | $4,785 |
| Tresiba Flextouch U-100 Insulin Degludec | 131 | 310 | 44 | $100K |
| Farxiga Dapagliflozin Propanediol | 130 | 298 | 35 | $159K |
| Humalog Kwikpen U-100 Insulin Lispro | 119 | 314 | 61 | $35K |
Brand drugs: 3,150 claims; generic drugs: 1,887 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Madhavi Gaddam $2,862 ($2,862 in general payments such as food, travel and fees) from 26 companies. The largest payer was Medtronic, Inc. with $937.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 16 | $937 |
| Amgen Inc. AMGN | 16 | $287 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $219 |
| Sequel Med Tech, LLC | 12 | $204 |
| Xeris Pharmaceuticals, Inc. | 6 | $126 |
| Dexcom, Inc. DXCM | 5 | $108 |
| Beta Bionics, Inc. BBNX | 6 | $99.8 |
| Insulet Corporation PODD | 5 | $94.07 |
| Madrigal Pharmaceuticals MDGL | 2 | $88.57 |
| Novo Nordisk Inc NVO | 4 | $80.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.